Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort
Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort. // The Breast. – URL: https://www.sciencedirect.com/science/article/pii/S0960977626002535?dgcid=rss_sd_all
Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort. The Breast. https://www.sciencedirect.com/science/article/pii/S0960977626002535?dgcid=rss_sd_all
“Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort.” The Breast.
@article{article67557,
title = {Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort},
journal = {The Breast},
url = {https://www.sciencedirect.com/science/article/pii/S0960977626002535?dgcid=rss_sd_all}
}
ABSTRACT Objectives The aim of this study was to determine whether certain cephalometric findings can predict the future need for orthognathic surgery (OS) in cleft lip (CL), cleft palate (CP), unilateral cleft lip and palate (UCLP),...